US Stock MarketDetailed Quotes

MXCT MaxCyte

Watchlist
  • 3.620
  • -0.150-3.98%
Close Feb 25 16:00 ET
381.85MMarket Cap-10.65P/E (TTM)

About MaxCyte Company

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.

Company Profile

SymbolMXCT
Company NameMaxCyte
Listing DateJul 30, 2021
Issue Price13.00
Founded1998
CEOMr. Maher Masoud
MarketNASDAQ
Employees143
Fiscal Year Ends12-31
Address9713 Key West Avenue,Suite 400
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-301-944-1700

Company Executives

  • Name
  • Position
  • Salary
  • Maher Masoud
  • President, Chief Executive Officer and Director
  • 890.37K
  • Douglas J Swirsky
  • Chief Financial Officer and Principal Accounting Officer
  • 1.19M
  • David I. Sandoval
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Thomas M. Ross
  • Executive Vice President, Global Sales
  • --
  • Dr. Richard H. Douglas, PhD
  • Non-Executive Chairman of the Board
  • 190.49K
  • Cynthia Lynne Collins
  • Director
  • --
  • Patrick J Balthrop Sr
  • Independent Director
  • 155.49K
  • Dr. Yasir B. Al-Wakeel
  • Independent Director
  • 238.53K
  • Rekha Hemrajani, M.B.A.
  • Independent Director
  • 243.03K
  • Stanley Charles Erck
  • Independent Director
  • 162.24K
  • John Joseph Johnston
  • Independent Director
  • 160.49K
  • William Wade Brooke
  • Independent Director
  • 177.24K
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.